Bryan, Garnier & Co acts as the Sole Financial Advisor to BICO in the sale of Nanoscribe to LAB14, a subsidiary to German RSBG
Bryan, Garnier & Co conducted a competitive process involving Tier 1 financial sponsors and trade buyers. Bryan, Garnier & Co advised BICO on deal strategy, buyer selection, due diligence management, transaction structure and contract negotiations.
This marks another landmark transaction for Bryan, Garnier & Co’s industrial technology practice and is a further demonstration of its expertise in public M&A and deep tech transactions. Other notable deep tech transactions include the sale of SUSS MicroOptics to Focuslight, the sale of Telops to Photonis and the sale of dp polar to 3D Systems.
Nanoscribe is a high-precision 3D printing technology company, specialising in two-photon polymerization (2PP). The company provides innovative solutions for microfabrication, enabling the creation of complex structures at the micro- and nanoscale. Nanoscribe’s systems are widely used in research, industry, and product development across fields like photonics, biomedicine, and micro-optics. By pushing the boundaries of additive manufacturing, Nanoscribe empowers scientists and engineers to accelerate breakthroughs in micro- and nanotechnology.
LAB14 is a cutting-edge research and technology hub focused on advancing micro- and nanotechnology for diverse industries. Specialising in high-precision fabrication and innovative material solutions, LAB14 provides state-of-the-art facilities for the development of next-generation microelectronics, photonics, and advanced materials.
With a mission to bridge the gap between scientific research and industrial applications, LAB14 collaborates with academic institutions, startups, and established enterprises to accelerate innovation. The centre fosters a multidisciplinary approach, enabling breakthroughs that transform concepts into scalable technologies, driving the future of microfabrication and nano-engineering.
